← Every company

Novartis AG SEC Filings

What Novartis AG has told the SEC happened, by the 8-K items and forms it filed under: when it reported results, who joined or left, what it bought or sold, and whether its auditor or its accounts ever changed.

NVS overview →
Filings on file
19
since Jan 25, 2017
Warning signs
0
none filed
Last results
—
8-K item 2.02
Industry
Pharmaceutical Preparations
SIC 2834

Newest first

Each label is a form type or an 8-K item as filed; each row links to the filing.

FiledWhat it reportsDocument
Sep 29, 2025
Tender offer
SC TO-T
Read ↗
May 27, 2025
Tender offer
SC TO-T
Read ↗
Jul 5, 2024
Tender offer
SC TO-T
Read ↗
Apr 11, 2024
Tender offer
SC TO-T
Read ↗
Dec 5, 2019
Tender offer
SC TO-T
Read ↗
Apr 17, 2018
Tender offer
SC TO-T
Read ↗
Dec 7, 2017
Tender offer
SC TO-T
Read ↗

Source: Novartis AG's EDGAR filing history, the last ten years. The labels are the form types and 8-K item numbers the company filed under, not a reading of what it wrote — an item 5.02 can be a chief executive fired or a director retiring on schedule — so each row links to the filing.

More on NVS

Related datasets